Registration number (WIID)Project No.TitleStatus
9499LVS EN ISO 10993-17:2003Biological evaluation of medical devices - Part 17: Establishment of allowable limits for leachable substancesAtcelts
9472LVS EN 30993-5:1994Biological evaluation of medical devices - Part 5: Tests for cytotoxicity - in vitro methods (ISO 10993-5:1992)Atcelts
31982LVS EN ISO 10993-10:2009Biological evaluation of medical devices - Part 10: Tests for irritation and delayed-type hypersensitivity (ISO 10993-10:2002, including Amd 1:2006)Atcelts
31999LVS EN ISO 10993-13:2009Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices (ISO 10993-13:1998)Atcelts
32006LVS EN ISO 10993-6:2009Biological evaluation of medical devices - Part 6: Tests for local effects after implantation (ISO 10993-6:2007)Atcelts
23327LVS EN ISO 10993-4:2003 /A1:2006Biological evaluation of medical devices - Part 4: Selection of tests for interactions with bloodAtcelts
9497LVS EN ISO 10993-5:1999Biological evalution of medical devices - Part 5: Tests for in vitro cytotoxicityAtcelts
9478LVS EN ISO 10993-11:1995Biological evalution of medical devices - Part 11: Tests for systemic toxicityAtcelts
9486LVS EN ISO 10993-12:1996Biological evalution of medical devices - Part 12: Sample preparation and reference materialsAtcelts
9494LVS EN ISO 10993-16:1997Biological evalution of medical devices - Part 16: Toxicokinetic study design for degradation products and leachablesAtcelts
Displaying 91-100 of 192 results.